138 related articles for article (PubMed ID: 18614761)
1. High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE).
Chamberlain AM; Folsom AR; Heckbert SR; Rosamond WD; Cushman M
Blood; 2008 Oct; 112(7):2675-80. PubMed ID: 18614761
[TBL] [Abstract][Full Text] [Related]
2. Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women.
Everett BM; Glynn RJ; Buring JE; Ridker PM
J Thromb Haemost; 2009 Apr; 7(4):588-96. PubMed ID: 19187075
[TBL] [Abstract][Full Text] [Related]
3. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.
Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K
Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572
[TBL] [Abstract][Full Text] [Related]
4. Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
Folsom AR; Lutsey PL; Nambi V; deFilippi CR; Heckbert SR; Cushman M; Ballantyne CM
Vasc Med; 2014 Feb; 19(1):33-41. PubMed ID: 24558027
[TBL] [Abstract][Full Text] [Related]
5. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.
Lutsey PL; Folsom AR; Heckbert SR; Cushman M
J Thromb Haemost; 2009 Oct; 7(10):1639-48. PubMed ID: 19656279
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.
Steffen LM; Cushman M; Peacock JM; Heckbert SR; Jacobs DR; Rosamond WD; Folsom AR
J Thromb Haemost; 2009 May; 7(5):746-51. PubMed ID: 19175496
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy.
Ferroni P; Roselli M; Riondino S; Guadagni F
J Thromb Haemost; 2014 Dec; 12(12):2049-53. PubMed ID: 25256037
[TBL] [Abstract][Full Text] [Related]
8. Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
van Capelleveen JC; Bochem AE; Boekholdt SM; Mora S; Hoogeveen RC; Ballantyne CM; Ridker PM; Sun W; Barter PJ; Tall AR; Zwinderman AH; Kastelein JJP; Wareham NJ; Khaw KT; Hovingh GK
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775061
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
Folsom AR; Tang W; Roetker NS; Heckbert SR; Cushman M; Pankow JS
Am J Hematol; 2015 Nov; 90(11):1047-51. PubMed ID: 26260105
[TBL] [Abstract][Full Text] [Related]
10. Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies.
Bell EJ; Agarwal SK; Cushman M; Heckbert SR; Lutsey PL; Folsom AR
Am J Hypertens; 2016 May; 29(5):634-40. PubMed ID: 26306405
[TBL] [Abstract][Full Text] [Related]
11. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.
Zakai NA; McClure LA; Judd SE; Safford MM; Folsom AR; Lutsey PL; Cushman M
Circulation; 2014 Apr; 129(14):1502-9. PubMed ID: 24508826
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
13. Body height and risk of venous thromboembolism: The Tromsø Study.
Braekkan SK; Borch KH; Mathiesen EB; Njølstad I; Wilsgaard T; Hansen JB
Am J Epidemiol; 2010 May; 171(10):1109-15. PubMed ID: 20418276
[TBL] [Abstract][Full Text] [Related]
14. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study.
Svartberg J; Braekkan SK; Laughlin GA; Hansen JB
Eur J Endocrinol; 2009 May; 160(5):833-8. PubMed ID: 19208774
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
Folsom AR; Tang W; George KM; Heckbert SR; MacLehose RF; Cushman M; Pankow JS
Thromb Res; 2016 Mar; 139():44-9. PubMed ID: 26916295
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort.
Folsom AR; Lutsey PL; Astor BC; Cushman M
Thromb Haemost; 2009 Oct; 102(4):615-9. PubMed ID: 19806245
[TBL] [Abstract][Full Text] [Related]
17. Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study.
Roetker NS; MacLehose RF; Hoogeveen RC; Ballantyne CM; Basu S; Cushman M; Folsom AR
Thromb Haemost; 2018 Nov; 118(11):1940-1950. PubMed ID: 30296818
[TBL] [Abstract][Full Text] [Related]
18. Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology.
Ohira T; Folsom AR; Cushman M; White RH; Hannan PJ; Rosamond WD; Heckbert SR
Br J Haematol; 2010 May; 149(4):606-12. PubMed ID: 20230397
[TBL] [Abstract][Full Text] [Related]
19. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis.
Wattanakit K; Lutsey PL; Bell EJ; Gornik H; Cushman M; Heckbert SR; Rosamond WD; Folsom AR
Thromb Haemost; 2012 Sep; 108(3):508-15. PubMed ID: 22782466
[TBL] [Abstract][Full Text] [Related]
20. Serum albumin and risk of venous thromboembolism.
Folsom AR; Lutsey PL; Heckbert SR; Cushman M
Thromb Haemost; 2010 Jul; 104(1):100-4. PubMed ID: 20390234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
